Valeant Pharmaceuticals International Inc names Joseph Papa as new chief executive

Published:

Papa, 60, had been CEO of Perrigo since 2006

LAVAL, Que. — Embattled drug company Valeant Pharmaceuticals International Inc. has named Joseph Papa as its new chairman and chief executive.

Win Big With Our Small Cap Picks

 

The company says Papa, who was chairman and CEO of drug company Perrigo in the U.S., is expected to join Valeant early next month.

Read the full article at: business.financialpost.com

Related articles

Recent articles